cell 639 words KG: microglia
Contents

Microglia in Alzheimer's Disease Neurodegeneration

🧫 Cell Type Info
Cell Typemicroglia
Associated DiseasesAlzheimer's disease, cardiovascular diseases, neurodegeneration, neuroinflammation, stroke
Related GenesALS, BDNF, C3, CD33
Linked Hypotheses789 hypotheses

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (191)

APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
APOE-TREM2 Interaction Modulation
Score: 0.74
Proteostasis Enhancement via APOE Chaperone Targeting
Score: 0.72
APOE Isoform Conversion Therapy
Score: 0.72
Axonal RNA Transport Reconstitution
Score: 0.70
Context-Dependent CRISPR Activation in Specific Neuronal Sub
Score: 0.68
...
Score: 0.68
Astrocytic Connexin-43 Upregulation Enhances Neuroprotective
Score: 0.68
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A
Score: 0.67
RNA Granule Nucleation Site Modulation
Score: 0.66
Mitochondrial RNA Granule Rescue Pathway
Score: 0.66
The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
Score: 0.65
Oligodendrocyte White Matter Vulnerability
Score: 0.65
Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro
Score: 0.64
Transglutaminase-2 Cross-Linking Inhibition Strategy
Score: 0.64
Multi-Modal CRISPR Platform for Simultaneous Editing and Mon
Score: 0.63
TFEB-PGC1α Mitochondrial-Lysosomal Decoupling
Score: 0.62
Restoring Neuroprotective Tryptophan Metabolism via Targeted
Score: 0.61
Complement-Mediated Synaptic Pruning Dysregulation
Score: 0.61
Epigenetic Memory Reprogramming for Alzheimer's Disease
Score: 0.61
← Prevpg 9/10Next →

Related Analyses (30)

Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · completed
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived

Related Experiments (30)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90
Brain Connectivity-Targeted tACS Trial in Early AD
clinical · proposed · Score: 0.51
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.45
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.45

See Also (15)

GFAP in Alzheimer's Disease
biomarker · Pages share 18 hypotheses
IL-6 (Interleukin-6) in Neurodegeneration
biomarker · Pages share 136 hypotheses
Eye-Tracking Digital Markers in Alzheimer's Disease
biomarker · Pages share 18 hypotheses
Gait Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
ASL Perfusion Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses

Knowledge Graph (12 edges)

VCP associated_with microglia
mBDNF associated_with microglia
microglia associated_with BDNF
EGFR expresses microglia
GRN associated_with microglia
BIN1 associated_with microglia
CLU associated_with microglia
GFP associated_with microglia
ABCA1 associated_with microglia
GDNF associated_with microglia

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.